InsideArbitrage Event Driven Monitor – June 9, 2023

Quick updates on the event driven strategies we follow on InsideArbitrage.

Subscribe to receive our Event Driven Monitor by email every morning before the market opens.

Merger Arbitrage

1. STSA: Shin Nippon Biomedical Laboratories completes the acquisition of Satsuma Pharmaceuticals.
2. DSEY: Shareholders of Diversey Holdings approved the company’s merger with Solenis at a special meeting of shareholders.
3. FRG: Franchise Group and members of the senior management team of the company led by Brian Kahn made the required filings with the FTC and the DOJ on May 24, 2023. The initial 30-day waiting period will expire on June 23, 2023. The ‘go-shop’ period with respect to the acquisition of Franchise Group expired.

Only plus or premium subscribers can access this post. Subscribe today.